- Research works
- 5 ▲ 376% vs 2018-21
- Citations
- 76 14.5 per fractional work
- Top-10% rate
- 10.3% all institutions 10.0%
- Open access
- 88% world 40%
- International
- 66% world 18%
Not ranked overall: Vitargent (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Vitargent (China) work in?
In all years, 44% of research at Vitargent (China) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (23%), Pharmacology, Toxicology and Pharmaceutics (12%). It does 1.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 8 fields, with their numbers
- Health Sciences244.3%
- Medicine243.2%
- Veterinary01.1%
- Life Sciences238.4%
- Physical Sciences117.3%
- Environmental Science110.5%
- Engineering03.6%
- Chemistry03.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 43.0×. Every wedge is a field page.
All 7 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics42.99×0 works
- Veterinary11.74×0 works
- Medicine2.85×2 works
- Environmental Science2.12×0 works
- Biochemistry, Genetics and Molecular Biology1.85×0 works
- Agricultural and Biological Sciences1.01×0 works
- Engineering0.21×0 works
Who are the top researchers at Vitargent (China)?
Ranked on the quality score, Xueping Chen lead among researchers whose main affiliation is Vitargent (China).
- 1
Xueping Chen
China · #1,244,872 worldwide 1.2k citations · 43 works
Which research topics does Vitargent (China) publish most on?
By volume in 2022-now: Skin Protection and Aging, Wound Healing and Treatments, Advancements in Transdermal Drug Delivery and Sirtuins and Resveratrol in Medicine.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Skin Protection and Aging Dermatology 0 works
- 2 Wound Healing and Treatments Rehabilitation 0 works
- 3 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
- 4 Sirtuins and Resveratrol in Medicine Geriatrics and Gerontology 0 works
- 5 Biochemical effects in animals Physiology 0 works
- 6 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works
- 7 Tea Polyphenols and Effects Pathology and Forensic Medicine 0 works
- 8 Autophagy in Disease and Therapy Epidemiology 0 works
- 9 melanin and skin pigmentation Cell Biology 0 works
- 10 Healthcare and Venom Research Pharmacology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Vitargent (China)'s research output changed?
Output in 2022-2025 was 376% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shatin
- Union Hospital
- Hong Kong Jockey Club
- Hang Seng University of Hong Kong
- Hong Kong Science and Technology Parks Corporation
- Applied Science and Technology Research Institute
- Shatin Hospital
- Advanced Materials Enterprises (China)
- Radica Systems (China)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Vitargent (China). Posts are plain text and can be reported.